Accordingly, the overexpression of CDC42 was observed in many cancer tissues like thyroid, lung, head and neck, stomach, pancreatic, breast, colon, etc. CDC42 was highly expressed in 60% of human colorectal cancer even if no mutation has been detected [166]. This evidence concerns the gene CDC42 and colorectal cancer.